p120-catenin promotes innate antiviral immunity through stabilizing TBK1-IRF3 complex

Copyright © 2023. Published by Elsevier Ltd..

TBK1-IRF3 complex plays vital roles in antiviral immune responses, its regulatory mechanisms are currently incompletely understood. p120-catenin (p120), an armadillo-repeat protein, mainly regulates the stability of classical cadherins and the development of epithelial-to-mesenchymal transitions (EMTs). Here we report that p120 is a positive regulator of type I IFN production. Ectopic expression of p120 enhanced Vesicular stomatitis virus and Sendai-virus-induced type I IFN production, whereas knockdown of p120 expression suppressed type I IFN production. Mechanistically, p120 promoted phosphorylation of IRF3 via stabilizing the TBK1-IRF3 complex. Consistently, p120 knock down mice are more susceptible to VSV infection as indicated by higher tissue viral titers, less IFN-I production and greater infiltration of immune cells. This study reveals p120 as an important positive regulator in innate immunity and identifies that p120 facilitates host antiviral response through stabilizing TBK1-IRF3 complex.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:157

Enthalten in:

Molecular immunology - 157(2023) vom: 15. Mai, Seite 8-17

Sprache:

Englisch

Beteiligte Personen:

Wu, Haifeng [VerfasserIn]
Yan, Xiuqing [VerfasserIn]
Zhao, Liang [VerfasserIn]
Li, Xiang [VerfasserIn]
Li, Ximing [VerfasserIn]
Zhang, Yi [VerfasserIn]
Gu, Changping [VerfasserIn]
Yang, Fan [VerfasserIn]
Yan, Jingting [VerfasserIn]
Lou, Yalin [VerfasserIn]
Li, Yufei [VerfasserIn]
Yang, Li [VerfasserIn]
Qin, Xiaofeng [VerfasserIn]
Wang, Yuelan [VerfasserIn]

Links:

Volltext

Themen:

Antiviral Agents
Delta Catenin
EC 2.7.1.-
EC 2.7.11.1
Innate immunity
Interferon Regulatory Factor-3
Interferon Type I
Irf3 protein, mouse
Journal Article
P120-catenin
Protein Serine-Threonine Kinases
Research Support, Non-U.S. Gov't
TBK1-IRF3 complex
Tbk1 protein, mouse
Type I interferon
Virus infection

Anmerkungen:

Date Completed 01.05.2023

Date Revised 09.05.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.molimm.2023.03.013

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM354633015